Signs of an allergic reaction can include itchiness, a rash, hives, chest tightness, shortness of breath, and swelling of the throat, lips, mouth, or tongue
Typical Starting Protocol Sermorelin: 100-200 mcg subcutaneous CJC-1295 (no DAC / Mod GRF 1-29): 100-200 mcg subcutaneous Both injected simultaneously, same syringe or adjacent sites, at bedtime Frequency: 5 nights per week (Monday through Friday), cycling off weekends to reduce pituitary desensitization risk Total GHRH-equivalent stimulus per injection in the stack is therefore 200-400 mcg, which is within the dose range studied in sermorelin monotherapy trials [1] and in the Jett pharmacokinetic study for CJC-1295 [2]
These side effects are usually temporary and tend to diminish as your body adjusts to the medication
Research indicates it reduces pro-inflammatory cytokines like TNF-alpha, IL-6, and IL-1 beta, without broadly suppressing immune function the way corticosteroids do